LAB
HEALTHCAREStandard BioTools Inc
Live · NASDAQ · May 9, Close
What's Moving LAB Today?
No stock-specific AI insight has been generated for LAB yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$0.97
Fundamentals
Trading
LAB News
20 articles- Standard BioTools (LAB) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 6, 2026
- Standard BioTools Reports First Quarter 2026 Financial ResultsYahoo Finance·May 5, 2026
- Standard BioTools to Announce First Quarter 2026 Financial Results on May 5, 2026GlobeNewswire Inc.·Apr 21, 2026
- Standard BioTools (LAB) is One of the Best Life Sciences Penny Stocks, Here is WhyYahoo Finance·Apr 14, 2026
- Labrador Gold Welcomes Recent Announcement by the Ontario Government Concerning Accelerated Development of the Ring of Fire RoadYahoo Finance·Mar 26, 2026
- Labrador Gold Announces Closing of Change of Business and Acquisition of Units of Northern ShieldYahoo Finance·Mar 9, 2026
- Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 MillionMotley Fool·Feb 27, 2026
- Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 MillionMotley Fool·Feb 27, 2026
- CORRECTION – Labrador Gold Announces Voting Results of the 2026 Annual General and Special Meeting of ShareholdersYahoo Finance·Feb 25, 2026
- Labrador Gold Announces Voting Results of the 2026Yahoo Finance·Feb 24, 2026
- Labrador Gold Announces Voting Results of the 2026 Annual General and Special Meeting of ShareholdersYahoo Finance·Feb 24, 2026
- Standard BioTools: Q4 Earnings SnapshotYahoo Finance·Feb 24, 2026
- Standard BioTools Reports Fourth Quarter and Full Year 2025 Financial ResultsYahoo Finance·Feb 24, 2026
- Standard BioTools to Announce Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026Yahoo Finance·Feb 10, 2026
- Standard BioTools Completes Sale of SomaLogic to IlluminaYahoo Finance·Jan 30, 2026
- Standard BioTools (NASDAQ:LAB) shareholders have endured a 76% loss from investing in the stock five years agoYahoo Finance·Jan 24, 2026
- Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 RevenueYahoo Finance·Jan 8, 2026
- Institutional owners may consider drastic measures as Standard BioTools Inc.'s (NASDAQ:LAB) recent US$96m drop adds to long-term lossesYahoo Finance·Dec 28, 2025
- Penny Stocks To Watch In December 2025Yahoo Finance·Dec 1, 2025
- Molecular Instruments and Standard BioTools Announce Collaboration to Bring Amplified Multi-Omic Readouts to Imaging Mass CytometryYahoo Finance·Nov 19, 2025
All 20 articles loaded
Price Data
52-Week Range
$0.97
Fundamentals
Trading
About Standard BioTools Inc
Standard Biotools Inc. (LAB) is a pioneering biotechnology company dedicated to enhancing genomic analysis and biological research through cutting-edge tools and technologies. The firm specializes in developing high-performance products that cater specifically to laboratories engaged in genomics and proteomics, thereby significantly improving research precision and operational efficiency. By employing proprietary platforms, Standard Biotools enables researchers to expedite discoveries and elevate the standard of their scientific endeavors. Positioned strategically within the rapidly evolving biotechnology sector, LAB is well-equipped to address the growing need for advanced analytical solutions that are essential to the life sciences industry.